Admittedly it was a small study (only 100 patients) and it didn’t hit the national headlines (this week’s column could be called ‘What should have made the health headlines’) — possibly because it didn’t have the backing of big pharma PR teams. A study published last month by South London and Maudsley NHS Foundation Trust — one of the pre-eminent psychiatry hospitals — revealed some…